Drugs / Rubus occidentalis extract
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01964703 Comparator | Apr → Oct 2013 | prediabetes syndrome | Korea University Anam Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rubus occidentalis extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01964703 ↗ |
| Route | Oral | “Either 900 or 1800 mg per day of RO extract was administered orally.” PMID 27279471 ↗ Jun 2016 |